Le Lézard
Classified in: Health
Subject: SVY

Coronary Artery Bypass Graft Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026


NEW YORK, June 13, 2018 /PRNewswire/ -- Global Coronary Artery Bypass Graft Market: Overview
This report analyzes the current and future scenario of the global coronary artery bypass graft market.Increase in incidence of cardiovascular diseases, rise in adoption of endoscopic surgeries, favorable reimbursement policies, surge in medical tourism, and technological advancements are factors expected to drive the global coronary artery bypass graft market during the forecast period.

Read the full report: https://www.reportlinker.com/p05439380

The global market has been segmented based on product type, device type, technique, end-user, and region.

The global coronary artery bypass graft market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.It also provides information and data analysis of the global market with respect to the segments based on product type, device type, technique, end-user, and region.

A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section.Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market.

This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global coronary artery bypass graft market.

Global Coronary Artery Bypass Graft Market: Key Segments
Based on product type, the global coronary artery bypass graft market has been segmented into on-pump CABG, off-pump CABG, minimally invasive direct CABG, and conventional CABG. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of device type, the global coronary artery bypass graft market has been classified into tissue stabilizers, heart positioners, refractors, cannulas, cardiopulmonary bypass machines, endoscopic vessel harvesting systems, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on technique, the global coronary artery bypass graft market has been bifurcated into traditional vessel harvesting and endoscopic vessel harvesting. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of end-user, the global coronary artery bypass graft market has been divided into hospitals, cardiology clinics, and research & academic institutions.The segments have been analyzed based on health care infrastructure, government investment, and economic development in the regions.

The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Coronary Artery Bypass Graft Market: Regional Outlook
Geographically, the global coronary artery bypass graft market has been categorized into four major regions and the key countries in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, and Rest of Asia Pacific), and Rest of the World (RoW). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report
The report also profiles the major players in the market in terms of various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.Major players operating in the global coronary artery bypass graft market are Medtronic, Terumo Corporation, KARL STORZ GmbH & Co.

KG, Boston Scientific, Ethicon (a subsidiary of Johnson & Johnson), Neograft, Sorin Group, MAQUET Holding B.V. & Co.KG, Edwards Lifesciences, Vitalitec International, Inc., Novadaq Technologies Inc., and Genesee Biomedical, Inc. These players are adopting organic and in-organic growth strategies to expand product offerings, strengthen geographical reach, increase customer base, and garner market share.

The global coronary artery bypass graft market has been segmented as follows:

Global Coronary Artery Bypass Graft Market, by Product Type
On-pump CABG
Off-pump CABG
Minimally Invasive Direct CABG
Conventional CABG

Global Coronary Artery Bypass Graft Market, by Device Type
Tissue Stabilizer
Heart Positioners
Refractors
Cannulas
Cardiopulmonary Bypass Machines
Endoscopic Vessel Harvesting Systems
Others

Global Coronary Artery Bypass Graft Market, by Technique
Traditional Vessel Harvesting
Endoscopic Vessel Harvesting (EVH)

Global Coronary Artery Bypass Graft Market, by End-user
Hospitals
Cardiology Clinics
Research & Academic Institutions

Global Coronary Artery Bypass Graft Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
India
Japan
China
Rest of Asia Pacific
Rest of the World (RoW)

Read the full report: https://www.reportlinker.com/p05439380

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: